🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of Tylenol, asserting the firms concealed safety concerns that the pain reliever created to children's brain development.

This legal action arrives a month after Former President Trump publicized an unverified association between using Tylenol - alternatively called acetaminophen - while pregnant and autism spectrum disorder in offspring.

Paxton is filing suit against J&J, which formerly manufactured the drug, the only pain reliever recommended for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he said they "betrayed America by making money from suffering and marketing drugs without regard for the potential hazards."

Kenvue asserts there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These companies deceived for years, deliberately risking numerous people to increase profits," the attorney general, from the Republican party, stated.

The manufacturer said in a statement that it was "seriously troubled by the spread of false claims on the security of paracetamol and the likely effects that could have on the health of American women and children."

On its website, Kenvue also said it had "regularly reviewed the pertinent research and there is lacking reliable evidence that indicates a established connection between taking acetaminophen and autism."

Groups speaking for doctors and health professionals share this view.

ACOG has stated paracetamol - the primary component in acetaminophen - is among limited choices for expectant mothers to address pain and elevated temperature, which can create serious health risks if not addressed.

"In over twenty years of studies on the consumption of acetaminophen in pregnancy, no reliable research has conclusively proven that the consumption of acetaminophen in any period of gestation results in neurodevelopmental disorders in offspring," the group said.

This legal action mentions current declarations from the previous government in claiming the drug is allegedly unsafe.

Last month, the former president generated worry from health experts when he instructed expectant mothers to "resist strongly" not to consume Tylenol when unwell.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the usage of acetaminophen, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in young ones has not been proven.

Health Secretary Kennedy, who oversees the FDA, had promised in spring to undertake "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a limited time.

But experts cautioned that discovering a single cause of autism spectrum disorder - believed by scientists to be the result of a complex mix of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and disability that affects how people perceive and interact with the environment, and is identified using medical professional evaluations.

In his lawsuit, the attorney general - who supports Trump who is running for federal office - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the corporations "remove any promotional materials" that states Tylenol is safe for pregnant women.

This legal action parallels the complaints of a collection of parents of minors with autism and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in 2022.

The court threw out the legal action, declaring studies from the family's specialists was lacking definitive proof.